We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Denmark-based drug producer Novo Nordisk has announced that it has finished
compiling a European Medicines Agency dossier on a new blunt trauma treatment.
According to company sources, Indian generics producer Natco Pharma is to invest
some INL100mn (US$2.28mn) on a new unit to produce active ingredients for anti-cancer
drugs.
Following a decision by a US court in New Jersey, Germany's Schwarz Pharma is
to seek damages relating to its Univasc heart drug from Israeli generics major
Teva.
Israeli drugmaker Kamada has reportedly received orphan-drug
status from both the US FDA and European Medicines Agency, for a new congenital
emphysema treatment.
Studies conducted by Germany's research-based pharmaceuticals association, the
VFA, indicate that average prescription drug prices have remained largely stable
in 2004, rising by an average of between 5% and 10%.
Switzerland-based drug major Novartis and Germany's Schering AG are jointly
conducting development activity on a new anticancer compound known as PTK/ZK.
India's government has insisted that the country's new patent framework will
not increase prices of essential drugs, despite the concerns of leftwing parties
and international humanitarian groups, including Doctors without Borders.